Cardiologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Chiropractor providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dentist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dermatologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Family Physician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
OB-GYN providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Ophthalmologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Orthopedic Surgeon providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Pediatrician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Physical Therapist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Podiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Psychiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Sigalove specializes in treating both benign and malignant diseases of the breast. Experienced in minimally invasive techniques, she focuses on care with compassion, and emphasizes the team approach in fighting cancer. She strives to achieve the most optimal treatment with the best possible cosmetic outcome.
Dr. Sigalove has helped advance novel surgical techniques that minimize pain, maximize recovery, and enhance the appearance of the breast whether that is in the setting of lumpectomy or mastectomy. She holds multiple publications on nipple-sparing mastectomy with pre-pectoral reconstruction and has lectured extensively on this topic both nationally and internationally.
Dr. Sigalove has held the position of Breast Program Director at Northwestern Medicine Central DuPage Hospital and was Health System Clinician at Northwestern University Feinberg School of Medicine. She was selected by her peers as “Top Breast Cancer Surgeon” in Phoenix Magazine in 2023, “Top Cancer Doctor” in Chicago Magazine in 2017, and was chosen as “Top Doctor” by Castle Connolly in 2014 and 2017.
Certified by the American Board of Surgery, Dr. Sigalove completed her surgical residency at Rush Medical Center and Cook County Hospital in Chicago. She graduated from Rush Medical College and obtained her undergraduate degree in Neurobiology and Physiology from Northwestern University.
In her spare time, Dr. Sigalove loves to garden and hike with her husband and dogs, and she looks forward to every single visit of her now grown twins.
"I was diagnosed with breast cancer that had traveled to my lymph node in December 2021. Dr Sigalove's approach was absolutely professional. She explained the diagnosis by listening to my concerns and questions in a very thorough patient and caring manner, while outlining her best recommended approach for treatment. Dr. Sigalove completed my surgery to remove the cancerous tumor in February 2022. The surgical procedure went without a hitch and left little scarring. I was absolutely pleased with the care I received from Dr. Sigalove. I highly recommend her in the unfortunate event you are ever diagnosed with cancer. Happy to inform, I am in remission and my mammograms have been clean. I feel my best decision in finding a qualified surgeon for treatment was when I found Dr. Sigalove. P.S. Staff and timeliness for appointments were also above reproach! Was never in waiting room for more than five minutes!" C. Nelson
"Dr. Sigalove operated on me over a year ago and continues to follow me. She diagnosed cancer before I knew I had it. She has been very supportive and kind following me through my cancer journey. She is very proficient in her field. I could not ask for a more professional caregiver. Her office staff are also very efficient and friendly. I would be happy to recommend her to anyone needing surgery."
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Specializing in treating benign and malignant breast disease, Dr. Cox has a special interest in breast conservation and minimally-invasive techniques. With this emphasis, she helps each patient choose the best surgical and oncologic results while preserving as much normal breast tissue as possible.
After completing undergraduate and graduate degrees at California State University, Dr. Cox graduated from Flinders University of South Australia. She completed her general surgery training at Pennsylvania State University's Milton S. Hershey Medical Center and a Breast Surgical Oncology fellowship at The Cancer Institute of New Jersey/UMDNJ-Robert Wood Johnson Hospital.
In her spare time, Dr. Cox enjoys Bikram yoga and hiking in the Arizona foothills with her two shiba inus. She travels and, in particular, enjoys the beautiful cultures and histories of the Asian continent.
"Dr. Cox is a fantastic Dr./surgeon. I went to her after receiving positive cancer biopsy results. That in and of itself is super scary, let alone not knowing what was going to happen next. This wonderful, warm Dr. sat next to me and explained everything so I could understand it. Dr Cox took her time with me, she drew pictures to show me everything that was going on and what she was going to do. Dr. Cox tells you how it is in the most compassionate way. I felt very cared for. I had a lumpectomy with sentinel node biopsy. She did a beautiful job surgically. The follow up phone calls were made in a timely manner. Her staff is wonderful as well. I highly recommend Dr. Cox and going forward should I do mastectomy she will be my surgeon hands down!" -Deborah
"I took my wife to our 1st consultation. The experience was very informative. Dr Cox spent the time to go through all our options. She was so personable and kind I left her office with my wife feeling we have made the best choice in the valley. Looking forward to our journey with her on our team. I highly recommend her." -Pete
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Michele Sazama is a board-certified adult nurse practitioner with extensive clinical experience, including over twenty years working with oncology patients. She holds national specialty certifications as an Advanced Oncology Certified Nurse Practitioner (AOCNP) and Board-Certified Medical Affairs Specialist (BCMAS).
Dr. Sazama was an instructor for Johns Hopkins University School of Nursing for many years and continues to serve as adjunct faculty for the Arizona State University nursing program. She created and directed a formal clinical rotation in oncology for graduate and doctoral nursing candidates, helping Arizona students develop their ability to safely care for oncology patients.
Dr. Sazama practices evidence-based medicine with a holistic focus and respect for individual choice.
Her clinical interests include psychoneuroimmunology, stress response, coping mechanisms, biofeedback, culturally diverse healing modalities, metaphysical science, meditation, and neuroplasticity.
Karlee grew up in a small town in Southern Wisconsin and went on to attend St. Cloud State University in Minnesota, where she played NCAA college soccer. After earning a degree in biomedical science with magna cum laude honors, she pursued her passion for medicine by obtaining a Physician Assistant degree from Northern Arizona University. During her time at Northern Arizona University she was an Arizona Area Health Education Center Scholar, engaging in a comprehensive two year interprofessional program that focused on preparing healthcare professionals for practice in underserved communities. This experience combined hands-on clinical training with community based learning, fostering a deep understanding of diverse patient needs.
Outside of work she enjoys reading, running, yoga, and spending quality time with family. Her commitment to ongoing learning and staying current with the latest medical advancements ensures that she is always equipped to deliver high quality care to her patients.
Dr. Angeles is a board-certified general surgeon with advanced training in benign and malignant breast diseases. She is committed to a multidisciplinary approach to treating breast cancer, working closely with the other sub-specialists in oncology to provide the best treatment plan for each patient. She also incorporates oncoplastic techniques to provide optimal cosmetic outcomes after breast conservation surgery.
Dr. Angeles received her medical degree from Western University of Health Sciences, College of Osteopathic Medicine of the Pacific. She completed her general surgery residency at Philadelphia College of Osteopathic Medicine in Pennsylvania. Having a special interest in breast cancer, she went on to complete a breast surgical oncology fellowship at Medstar Washington Hospital Center in Washington, D.C
In her spare time, she loves to travel, support her sons at their basketball games, and hike during the cooler months in and around Arizona.
"I was referred to Dr. Angeles for a breast consult. I had been diagnosed with LCIS and she was very informative and thorough. She ended up doing another biopsy/lumpectomy and found a 2.5mm cancerous tumor. After another surgery to check my lymph nodes I was referred for radiation therapy. Dr. Angeles was so wonderful during this whole process. Her bedside manner is top notch. All her staff and nurses were amazing as well. I have had very little down time considering everything that has happened. She got the ball rolling quickly with all of my care and I am so grateful." -Cathie
"She is probably the most empathetic doctor I have ever met. She truly cares about her patients, not just the cancer, but your whole being. She reassuring and comforting when patients like me are at their worst. Highly recommend." -Ginny
Dr. Sigalove specializes in treating both benign and malignant diseases of the breast. Experienced in minimally invasive techniques, she focuses on care with compassion, and emphasizes the team approach in fighting cancer. She strives to achieve the most optimal treatment with the best possible cosmetic outcome.
Dr. Sigalove has helped advance novel surgical techniques that minimize pain, maximize recovery, and enhance the appearance of the breast whether that is in the setting of lumpectomy or mastectomy. She holds multiple publications on nipple-sparing mastectomy with pre-pectoral reconstruction and has lectured extensively on this topic both nationally and internationally.
Dr. Sigalove has held the position of Breast Program Director at Northwestern Medicine Central DuPage Hospital and was Health System Clinician at Northwestern University Feinberg School of Medicine. She was selected by her peers as “Top Breast Cancer Surgeon” in Phoenix Magazine in 2023, “Top Cancer Doctor” in Chicago Magazine in 2017, and was chosen as “Top Doctor” by Castle Connolly in 2014 and 2017.
Certified by the American Board of Surgery, Dr. Sigalove completed her surgical residency at Rush Medical Center and Cook County Hospital in Chicago. She graduated from Rush Medical College and obtained her undergraduate degree in Neurobiology and Physiology from Northwestern University.
In her spare time, Dr. Sigalove loves to garden and hike with her husband and dogs, and she looks forward to every single visit of her now grown twins.
"I was diagnosed with breast cancer that had traveled to my lymph node in December 2021. Dr Sigalove's approach was absolutely professional. She explained the diagnosis by listening to my concerns and questions in a very thorough patient and caring manner, while outlining her best recommended approach for treatment. Dr. Sigalove completed my surgery to remove the cancerous tumor in February 2022. The surgical procedure went without a hitch and left little scarring. I was absolutely pleased with the care I received from Dr. Sigalove. I highly recommend her in the unfortunate event you are ever diagnosed with cancer. Happy to inform, I am in remission and my mammograms have been clean. I feel my best decision in finding a qualified surgeon for treatment was when I found Dr. Sigalove. P.S. Staff and timeliness for appointments were also above reproach! Was never in waiting room for more than five minutes!" C. Nelson
"Dr. Sigalove operated on me over a year ago and continues to follow me. She diagnosed cancer before I knew I had it. She has been very supportive and kind following me through my cancer journey. She is very proficient in her field. I could not ask for a more professional caregiver. Her office staff are also very efficient and friendly. I would be happy to recommend her to anyone needing surgery."
Specializing in treating benign and malignant breast disease, Dr. Cox has a special interest in breast conservation and minimally-invasive techniques. With this emphasis, she helps each patient choose the best surgical and oncologic results while preserving as much normal breast tissue as possible.
After completing undergraduate and graduate degrees at California State University, Dr. Cox graduated from Flinders University of South Australia. She completed her general surgery training at Pennsylvania State University's Milton S. Hershey Medical Center and a Breast Surgical Oncology fellowship at The Cancer Institute of New Jersey/UMDNJ-Robert Wood Johnson Hospital.
In her spare time, Dr. Cox enjoys Bikram yoga and hiking in the Arizona foothills with her two shiba inus. She travels and, in particular, enjoys the beautiful cultures and histories of the Asian continent.
"Dr. Cox is a fantastic Dr./surgeon. I went to her after receiving positive cancer biopsy results. That in and of itself is super scary, let alone not knowing what was going to happen next. This wonderful, warm Dr. sat next to me and explained everything so I could understand it. Dr Cox took her time with me, she drew pictures to show me everything that was going on and what she was going to do. Dr. Cox tells you how it is in the most compassionate way. I felt very cared for. I had a lumpectomy with sentinel node biopsy. She did a beautiful job surgically. The follow up phone calls were made in a timely manner. Her staff is wonderful as well. I highly recommend Dr. Cox and going forward should I do mastectomy she will be my surgeon hands down!" -Deborah
"I took my wife to our 1st consultation. The experience was very informative. Dr Cox spent the time to go through all our options. She was so personable and kind I left her office with my wife feeling we have made the best choice in the valley. Looking forward to our journey with her on our team. I highly recommend her." -Pete
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Michele Sazama is a board-certified adult nurse practitioner with extensive clinical experience, including over twenty years working with oncology patients. She holds national specialty certifications as an Advanced Oncology Certified Nurse Practitioner (AOCNP) and Board-Certified Medical Affairs Specialist (BCMAS).
Dr. Sazama was an instructor for Johns Hopkins University School of Nursing for many years and continues to serve as adjunct faculty for the Arizona State University nursing program. She created and directed a formal clinical rotation in oncology for graduate and doctoral nursing candidates, helping Arizona students develop their ability to safely care for oncology patients.
Dr. Sazama practices evidence-based medicine with a holistic focus and respect for individual choice.
Her clinical interests include psychoneuroimmunology, stress response, coping mechanisms, biofeedback, culturally diverse healing modalities, metaphysical science, meditation, and neuroplasticity.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
